Professor Peter Palese | New COVID-19 Vaccines Aim to Increase Global Access and Protect Against Emerging Variants
About this episode
As COVID-19 continues to evolve, there is an urgent need for vaccines that are cheaper, easier to produce, and more effective against emerging variants of concern. This is especially important for low-income countries, which face challenges in accessing current vaccines. Peter Palese and his colleagues – Weina Sun, Adolfo García-Sastre and Florian Krammer – at the Icahn School of Medicine at Mount Sinai are developing innovative new COVID-19 vaccines based on the Newcastle disease virus – or ‘NDV’.
Original Article Reference
Summary of the papers: ‘Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice’, doi.org/10.1128/spectrum.01538-22; and ‘A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses’, doi.org/10.1128/spectrum.01538-22
Contact
For further information, you can connect with Professor Peter Palese at peter.palese@mssm.edu
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.